Company intelligence / Profile preview

Quanta Dialysis Technologies

Warwick, Warwickshire, United Kingdomquantadt.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product—the Quanta Dialysis System—has received FDA clearance for use in both acute and chronic care settings. It enables hospitals and clinics to deliver a range of dialysis therapies on a single compact device. Clinical pilots with the NHS have demonstrated efficacy comparable to traditional in-center regimens. The system was rapidly deployed during COVID‑19 to support emergency dialysis needs. No clinical trial data typical of drug development; performance validated through regulatory clearance and real-world use.

Therapeutic areas: Nephrology
Modalities: Device (Hemodialysis system)Non-pharmacological therapy (Renal replacement therapy device)
Industry: Therapeutic Medical Devices

Partnerships

NHS Trusts in the UK for clinical deployment/pilots during COVID‑19 response

Beyond the preview

Go deeper on Quanta Dialysis Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quanta Dialysis Technologies.

Explore the full profile